RAPGEF3 and Rickettsiosis: Also related to vascular function is recent work demonstrating that knockout or pharmacological inhibition of EPAC1 blocks adhesion to, and subsequent invasion of, endothelial cells by Rickettsia bacteria, demonstrating that EPAC1 may be a promising target for the treatment of rickettsioses [78].